Literature DB >> 27437086

Allele Frequencies of the Single Nucleotide Polymorphisms Related to the Body Burden of Heavy Metals in the Korean Population and Their Ethnic Differences.

Sang-Yong Eom1, Ji-Ae Lim2, Yong-Dae Kim1, Byung-Sun Choi3, Myung Sil Hwang4, Jung-Duck Park3, Heon Kim1, Ho-Jang Kwon2.   

Abstract

This study was performed to select single nucleotide polymorphisms (SNPs) related to the body burden of heavy metals in Koreans, to provide Korean allele frequencies of selected SNPs, and to assess the difference in allele frequencies with other ethnicities. The candidate-gene approach method and genome-wide association screening were used to select SNPs related to the body burden of heavy metals. Genotyping analysis of the final 192 SNPs selected was performed on 1,483 subjects using the VeraCode Goldengate assay. Allele frequencies differences and genetic differentiations between the Korean population and Chinese (CHB), Japanese (JPT), Caucasian (CEU), and African (YIR) populations were tested by Fisher's exact test and fixation index (F ST), respectively. The Korean population was genetically similar to the CHB and JPT populations (F ST < 0.05, for all SNPs in both populations). However, a significant difference in the allele frequencies between the Korean and CEU and YIR populations were observed in 99 SNPs (60.7%) and 120 SNPs (73.6%), respectively. Ten (6.1%) and 26 (16.0%) SNPs had genetic differentiation (F ST > 0.05) among the Korean-CEU and Korean-YIR comparisons, respectively. The SNP with the largest F ST value between the Korean and African populations was cystathionine-β-synthase rs234709 (F ST: KOR-YIR, 0.309; KOR-CEU, 0.064). Our study suggests that interethnic differences exist in SNPs associated with heavy metals of Koreans, and it should be considered in future studies that address ethnic differences in heavy-metal concentrations in the body and genetic susceptibility to the body burden of heavy metals.

Entities:  

Keywords:  Gene frequency; Genetic diversity; Metals; Single nucleotide polymorphism

Year:  2016        PMID: 27437086      PMCID: PMC4946415          DOI: 10.5487/TR.2016.32.3.195

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


INTRODUCTION

It is well known that heavy metals induce adverse health effects in humans, including kidney damage, bone loss, neurological disorders, developmental abnormalities, vascular diseases, and cancer (1,2). Even the general population that does not have occupational exposure is chronically exposed to a low concentration of heavy metals because heavy metals are widely distributed in the environment (1,3). Heavy-metal concentration in the body is affected by various factors such as age, sex, smoking, diet, and nutritional status, and the environmental exposure level is a critical factor in determining the body burden of heavy metal (1,3,4). However, heavy metals go through the processes of absorption, distribution, metabolism, and excretion, in which a number of genetic factors are involved directly or indirectly. Therefore, in addition to environmental factors, genetic factors and their interactions may also play important roles in determining heavy-metal concentrations in the body (5). Previous studies reported that single nucleotide polymorphisms (SNPs) of a gene involved in iron metabolism were associated with not only the iron level but also with the lead and cadmium levels (6,7). Furthermore, in a twin study, the blood cadmium concentration was more strongly affected by genetics than by environmental factors (8). Therefore, genetic predisposition can play an important role in the body burden of heavy metals. The blood cadmium and mercury levels in the general Korean population are approximately 2~4 times higher than the levels in the American population (9). Although consuming grains and shellfish was predicted to be a major factor in the heavy-metal high exposure levels of Korean populations (10), the general Korean population’s estimated total dietary intake of cadmium was not high compared to that of other nations and was considerably lower (about 30%) than the provisional tolerable weekly intake (11). This mismatch between external exposure and internal concentration indicates that there is the possibility that Koreans have a genetic predisposition associated with high absorption, low excretion, and high accumulation rates of heavy metals. Therefore, the goal of this study was to select SNPs related to the body burden of heavy metals, such as lead, mercury, cadmium, and arsenic, provide Korean allele frequencies of selected SNPs, and assess the difference in allele frequencies with other ethnicities.

MATERIALS AND METHODS

Study subjects

This study was based on a cohort established by the Korean Research Project on Integrated Exposure Assessment to Hazardous Materials for Food Safety (KRIEFS). The characteristics of this KRIEFS cohort and the method used to select the study subjects were described in detail in previous studies (12). Out of the 2,118 adults who enrolled in a KRIEFS cohort, 1,558 consented to participating in the genetic study. Among them, 71 subjects were excluded for the following reasons: incomplete data on heavy-metal exposure (n = 48) and insufficient blood sample (n = 23). Ultimately, 1,487 subjects were selected as study subjects. This study was approved by the Institutional Review Board of Dankook University Hospital, Republic of Korea (IRB No. 2013-03-008), and informed consent was obtained from all individual participants included in the study.

Selection of SNPs-related body burden of heavy metals in the Korean population and genotyping analysis

The candidate-gene approach method and genome-wide association screening using an exome chip were performed to select SNPs related to the body burden of heavy metals in the Korean population.

Candidate-gene approach

The genes involved in absorption, distribution, metabolism, and excretion of heavy metals were selected as candidate genes through a literature review, and databases search, such as Catalog of Published GWAS (13) and HuGE Navigator (14). SNPs located in the transcription regulatory region (promoter region or start codon) and the coding region (splice site, exon, or stop codon) of the selected candidate genes were selected as candidate SNPs using the Functional Element SNPs Database II (15). We searched the International HapMap Project database (HapMap Data Rel 27, population CHB and JPT/R-square cutoff 0.9, minor allele frequency cutoff 0.05) for the haplotype tagging SNP of each candidate gene and selected the candidate SNPs from this source.

Genome-wide association screening

After randomly selecting 500 people from the study subjects, genome-wide association screening was conducted using a Human Exome chipv1.2 (Illumina, San Diego, USA) in which 244,770 SNPs could be simultaneously analyzed. There were 783 SNPs not in Hardy-Weinberg equilibrium (HWE) (p < 0.001), and 309 SNPs had call rates of less than 95%. The average call rate of all samples was greater than 99.9%, with a minimum value of 99.4%. As a result of conducting a blind replication test on 20 randomly selected samples, the error rate of all samples was less than 0.05%, and the average concordance rate was 99.96%. For the SNPs located on autosomal chromosomes that satisfied the call rate (> 95%) and were in HWE (p > 0.001), the association with the marker of heavy-metal body burden (blood lead, blood cadmium, blood mercury, urinary cadmium and total arsenic) was evaluated by multiple regression analysis using the program PLINK, and 81 significant SNPs (p < 1.0 × 10−4) were selected.

Genotyping analysis

Ultimately, 192 SNPs were selected based on the candidate-gene approach method and genome-wide association screening. Genotyping analysis was performed on the selected 192 SNPs using the VeraCode Goldengate assay (Illumina, San Diego, CA, USA). An analysis was performed on 1,483 subjects who passed the DNA quality control (QC). The average call rate of the samples was 99.41%, and the average call rate of the SNPs was 99.38%. From 15 of the 192 total SNPs that were not in HWE, six SNPs with call rates less than 95% and two samples with call rates less than 95% were excluded from the final analysis. As a result of conducting a blind replication test on 19 randomly selected samples, high reproducibility was confirmed with an average concordance rate of 99.5%.

SNP frequencies in other ethnic populations

The frequencies of the selected SNPs in other ethnic populations were investigated using the Database of Single Nucleotide Polymorphisms (dbSNP build 142) and International Hap-Map DB (HapMap Data Rel #27 Phases I, II, and III). In this study, the gene frequencies in the Korean population were compared to those in four ethnic populations: Han Chinese individuals from Beijing, China (CHB), Japanese individuals from Tokyo, Japan (JTP), Caucasian individuals from Utah, USA of Northern and Western European ancestry from the Centre de’Etude du Polymorphism Humain-collection (CEU), and African Yoruba individuals in Ibadan, Nigeria (YRI).

Statistical analysis

HWE and allele frequency, as determined by the program PLINK, were used to analyze the data for 192 SNPs in the Korean individuals in this study. Based on the minor allele in the Korean population, the allele frequencies in each ethnic group were calculated. For the 163 SNPs that passed SNP QC, the difference in SNP frequencies between the Korean populations and other ethnic groups was compared using Fisher’s exact test. For each of the SNPs, we used Bonferroni correction for multiple tests and set the statistical significance threshold to p-value < 3.1 × 10−4 (0.05/163 SNPs = 3.1 × 10−4). Genetic differentiation among four ethnicities was measured by the Fixation index (FST), which describes the degree of population differentiation based on genetic polymorphisms (16). FST among a pairwise comparison between different ethnic groups was schematized with a Manhattan plot. FST at 0.05 to 0.15 was interpreted as moderate genetic differentiation, 0.15 to 0.25 was high genetic differentiation, and above 0.25 was very high genetic differentiation.

RESULTS

The study was conducted on 1,487 Korean subjects to calculate the allele frequencies of SNPs involved in the body burden of heavy metals, and their demographic characteristics and the level of heavy metals in subjects are presented in Table 1. The mean age of study subjects was 45.5 ± 14.5 years, 56.8% of all subjects was females. The geometric means of blood lead, mercury, cadmium levels in all subjects were 2.21 μg/dL, 4.05 μg/L and 1.06 μg/L, respectively. The geometric mean concentrations of cadmium and total arsenic in urine were 1.06, 102.7 μg/g creatinine, respectively.
Table 1

General characteristics of study subjects

N (%)
Total subjects1,487
GenderMales643 (43.2)
Females844 (56.8)
Age, mean ± std.45.5 ± 14.5
Age groups−29255 (17.2)
30~39266 (17.9)
40~49341 (22.9)
50~59334 (22.5)
60+291 (19.6)
Smoking historyNever smokers966 (65.0)
Ex-smokers243 (16.3)
Current smokers278 (18.7)
Alcohol useNon-drinkers362 (24.3)
Drinkers1125 (75.7)
Heavy metal levels*
Blood lead, unit: μg/dL2.21 (2.17, 2.26)
Blood mercury, unit: μg/L4.05 (3.91, 4.19)
Blood cadmium, unit: μg/L1.06 (1.03, 1.09)
Urinary cadmium, unit: μg/g creatinine1.09 (1.05, 1.13)
Urinary total arsenic, unit: μg/g creatinine102.7 (98.03, 107.60)

Presented as geometric mean and 95% confidence intervals.

Table 2 shows the annotation information, minor allele frequency and selection rationale for the 192 selected SNPs. For the 163 SNPs that passed SNP QC, the allele frequency of minor (variant) alleles in the Korean population and the allele frequencies in CHB, JPT, CEU, and YIR were compared by pairwise comparison; the results are presented in Supplemental Table 1. Six SNPs (3.7%) showed a statistically significant difference in allele frequency between the Korean and CHB populations, and eight SNPs (4.9%) differed between the Korean and JPT populations. However, there was no genetic differentiation among populations because FST was less than 0.05 in all SNPs. In the allele frequency comparison between the Korean and CEU populations, significant differences were found in 99 SNPs (60.7%), and FST was above 0.05 in 10 SNPs (6.1%). In comparison between the Korean and YIR populations, 120 SNPs (73.6%) showed a significant difference in the allele frequency, and FST was above 0.05 in 26 SNPs (16.0%). Therefore, the biggest genetic divergence was observed between the Korean and YIR populations (Fig. 1).
Table 2

Information about the 192 SNPs and allele frequencies tested in this study

rs IDChr.GeneLocationMinor alleleMAFSelection rationaleRelated heavy metals
rs19483681S1PR1/OLFM3IntergenicA0.003Exome chip basedCd
rs7142821GPR177IntronA0.419Exome chip basedCd
rs37369301ATP6V1G3ComplexT0.057Candidate gene approachedCd
rs26668391CENPFCodingT0.163Exome chip basedCd
rs345454621SLC2A7CodingT0.050Exome chip basedHg
rs112652631DUSP23/CRPIntergenicA0.170Exome chip basedCd
rs133067311SOAT1CodingG0.380Candidate gene approachedCd, Hg
rs111180751RRP15CodingC0.070Exome chip basedHg
rs118051941NUP133CodingC0.140Exome chip basedCd
rs24794091BSND/PCSK9IntergenicA0.366Exome chip basedCd
rs353512921LAPTM5CodingA0.065Exome chip basedCd
rs412684741C1orf68CodingA0.068Exome chip basedPb
rs12848521FLVCR1/VASH2IntergenicG0.446Candidate gene approachedCd
rs582751681SLC35F3IntronA0.282Exome chip basedCd
rs14764131MTHFRIntronA0.176Candidate gene approachedAs
rs48456251IL6RIntronT0.443Exome chip basedPb
rs2677331ANXA9CodingG0.077Exome chip basedPb
rs26985302PELI1/HSPC159IntergenicA0.350Candidate gene approachedCd, Pb
rs14574512LOC729348/LOC100131818IntergenicA0.172Candidate gene approachedCd
rs46643252RBMS1IntronG0.315Exome chip basedCd
rs126232342MRPS9/GPR45IntergenicG0.476Exome chip basedCd
rs11306092RRM2UTRG0.338Candidate gene approachedPb
rs21657382NCOA1/ITSN2IntergenicG0.387Exome chip basedHg
rs611972182LOC100128572/IQCA1IntergenicA0.271Exome chip basedHg
rs22870592NOL10CodingT0.114Exome chip basedHg
rs104552CYBRD1UTRA0.331Candidate gene approachedPb
rs37476733TNK2CodingT0.111Exome chip basedCd
rs22932323MUC4CodingT0.219Exome chip basedCd
rs38176723TFRCCodingA0.175Candidate gene approachedCd
rs729530983C3orf30UTRG0.067Exome chip basedHg
rs76409783CMTM6IntronT0.057Exome chip basedCd
rs8320383GABRR3IntronG0.452Candidate gene approachedPb, Cd
rs67999693RAD18/OXTRIntergenicG0.358Exome chip basedCd
rs17998523TFCodingT0.218Candidate gene approachedCd, Pb
rs38041413TFRCIntronA0.212Candidate gene approachedCd
rs27188123TOPBP1/TFIntergenicA0.490Candidate gene approachedCd
rs18300843TF/SRPRBIntergenicA0.472Candidate gene approachedCd, Pb
rs751238673CCDC50CodingT0.048Exome chip basedCd
rs38116473TFIntronA0.419Candidate gene approachedCd
rs15610723SOX2OT/ATP11BIntergenicC0.180Exome chip basedHg
rs22767903MFI2CodingT0.061Candidate gene approachedCd
rs10492963TFCodingT0.266Candidate gene approachedCd
rs341939824NEIL3CodingG0.118Exome chip basedHg
rs745115004FAT1CodingA0.091Exome chip basedHg
rs115561674PET112LCodingA0.059Exome chip basedCd
rs40734RASSF6/IL8IntergenicA0.367Candidate gene approachedAs
rs27252644ABCG2IntronG0.219Candidate gene approachedHg
rs172081875TMCO6CodingG0.258Exome chip basedHg
rs75795SEPP1UTRA0.329Candidate gene approachedHg
rs38227515GLRXIntronC0.294Candidate gene approachedAs
rs20525505ARSBIntronG0.452Candidate gene approachedCd, Pb
rs38778995SEPP1Coding-0.000Candidate gene approachedHg
rs131883865GHR/LOC100129630Intergenic-0.000Candidate gene approachedCd, Pb
rs23541245MRPL36/LOC728613IntergenicG0.255Exome chip basedCd
rs11304355FABP6ComplexT0.456Exome chip basedCd
rs37497795SLC25A2CodingG0.095Exome chip basedHg
rs18013945MTRRComplexG0.283Candidate gene approachedCd
rs37654676GLP1RCodingT0.252Exome chip basedHg
rs23012276HLA-DPA1IntronC0.073Exome chip basedCd, Hg
rs31299536C6orf10/BTNL2IntergenicT0.083Exome chip basedCd
rs761000896LOC729792CodingT0.203Exome chip basedHg
rs18006296TNF/LTAIntergenicA0.068Candidate gene approachedCd
rs172705616SLC17A1IntronA0.145Candidate gene approachedPb, Cd
rs131949846BTN1A1/BTN2A1IntergenicT0.007Candidate gene approachedCd, Pb
rs173427176SLC17A1IntronT0.008Candidate gene approachedCd, Pb
rs20715936ATP6V1G2UTRT0.084Candidate gene approachedHg
rs39573566GSTA1/GSTA5IntergenicT0.156Candidate gene approachedHg
rs9323166SCGN/LRRC16AIntergenicC0.136Candidate gene approachedCd, Pb
rs122161256HIST1H1A/TRIM38IntergenicT0.122Candidate gene approachedCd, Hg
rs17999456HFEComplexG0.048Candidate gene approachedCd, Pb
rs93572836DNAH8CodingA0.314Candidate gene approachedCd
rs45169706WTAP/SOD2Intergenic-0.000Candidate gene approachedCd, Pb
rs22740896LRRC16AIntronA0.031Candidate gene approachedCd, Pb
rs11832016SLC17A1IntronA0.143Candidate gene approachedHg
rs178839016GCLC/KLHL31IntergenicT0.115Candidate gene approachedHg
rs28588816HLA-DQB1/HLA-DQA2IntergenicG0.048Exome chip basedHg
rs37367816BTN1A1CodingG0.314Candidate gene approachedHg
rs21426726MYLIP/GMPRIntergenicC0.264Exome chip basedPb
rs9722756LOC728666/RSPO3IntergenicG0.458Candidate gene approachedCd, Pb
rs358682977GALNTL5CodingC0.196Exome chip basedCd
rs1945247STEAP2ComplexA0.213Candidate gene approachedPb
rs27180217SEPT7/EEPD1IntergenicT0.480Exome chip basedCd
rs132250977LOC100288724/GIMAP4IntergenicG0.188Exome chip basedCd
rs47222667STK31ComplexA0.260Exome chip basedPb
rs133066987PON1CodingG0.086Candidate gene approachedCd
rs298807INHBA/C7orf10IntergenicG0.144Candidate gene approachedCd, Pb
rs6627PON1CodingA0.355Candidate gene approachedPb
rs69719257DGKBIntronT0.078Exome chip basedCd
rs11066348ATP6V1B2IntronA0.211Candidate gene approachedHg
rs81916648NEIL2ComplexT0.193Exome chip basedCd
rs115444848TOP1MTCodingA0.063Exome chip basedHg
rs47327488ESCO2CodingT0.200Exome chip basedCd, Hg
rs748463858C8orf86CodingC0.106Exome chip basedCd
rs170582078SCARA5CodingG0.320Candidate gene approachedPb, Cd
rs48725118PPP3CC/SORBS3IntergenicT0.084Exome chip basedPb
rs18004359ALADCodingC0.073Candidate gene approachedPb
rs108187089OR1N1CodingG0.099Exome chip basedCd
rs374039310AS3MTIntronC0.253Candidate gene approachedAs
rs74357210CYP17A1UTRG0.496Candidate gene approachedAs
rs104677810AS3MTUTRC0.385Candidate gene approachedAs
rs1074913810NRAPCodingT0.419Exome chip basedHg
rs446226210IPMK/ZWINTIntergenicT0.078Exome chip basedHg
rs71762010ABCC2UTRA0.222Candidate gene approachedHg
rs1119143910AS3MTCodingC0.014Candidate gene approachedAs
rs1074883510AS3MTIntronA0.491Candidate gene approachedAs
rs15669710GSTO2CodingC0.259Candidate gene approachedCd
rs1119145310AS3MTIntronC0.250Candidate gene approachedAs
rs708510410C10orf32/AS3MTIntergenicG0.435Candidate gene approachedAs
rs229723510GSTO2UTRG0.149Candidate gene approachedAs
rs492510GSTO1CodingA0.150Candidate gene approachedAs
rs227369710ABCC2CodingA0.080Candidate gene approachedCd
rs374006610ABCC2CodingA0.245Candidate gene approachedHg
rs374039010AS3MTIntronA0.250Candidate gene approachedAs
rs1089169211FAM55ACodingC0.382Exome chip basedCd
rs169511GSTP1CodingG0.176Candidate gene approachedCd, Hg
rs414918211SLC22A8IntronC0.316Candidate gene approachedHg
rs1156849611SLC22A8Coding-0.000Candidate gene approachedHg
rs4556603911SLC22A8Coding-0.000Candidate gene approachedHg
rs7703028611SNHG1/SNORD28Intergenic-0.000Candidate gene approachedHg
rs1004746211KIAA0999IntronG0.499Candidate gene approachedCd, Pb
rs1236220911CCDC83CodingG0.082Exome chip basedHg
rs23691811PCSK7IntronC0.444Candidate gene approachedCd, Hg
rs475280511PTPRJIntronG0.211Exome chip basedCd
rs414917011SLC22A6UTRA0.278Candidate gene approachedHg
rs196512LOC341378/CKAP4IntergenicG0.345Candidate gene approachedHg
rs1222965412LOC100131138/CUX2IntergenicG0.139Exome chip basedPb
rs1111124512NAV3/SYT1IntergenicC0.080Exome chip basedCd
rs229107512SLCO1B1CodingT0.422Candidate gene approachedAs
rs797523212VDRIntronA0.249Candidate gene approachedPb
rs246419612HNF1ACodingC0.454Candidate gene approachedPb
rs1106628012LOC100287871IntronA0.178Exome chip basedPb
rs430484012CLEC4DCodingG0.160Exome chip basedHg
rs88538912GPR133IntronG0.423Exome chip basedPb
rs156437012SLCO1B1IntronC0.259Candidate gene approachedAs
rs1084297112PZPCodingT0.063Exome chip basedHg
rs1712471512LARP4ComplexC0.079Exome chip basedCd, Hg
rs75734312VDRIntronA0.190Candidate gene approachedPb
rs180080212ERP27/MGPIntergenicC0.340Candidate gene approachedPb
rs67112ALDH2CodingA0.158Exome chip basedPb
rs154441012VDRIntronA0.051Candidate gene approachedPb
rs6068362112OR6C70CodingG0.489Exome chip basedHg
rs1727886813LATS2/SAP18IntergenicC0.366Exome chip basedHg
rs63643713RFC3/NBEAIntergenicG0.132Exome chip basedCd, Hg
rs97396814FLJ43390/KCNH5IntergenicG0.059Candidate gene approachedCd
rs1287934614SLC7A8UTRT0.486Candidate gene approachedHg
rs1258811814SLC7A8IntronG0.096Candidate gene approachedHg
rs3469115314SLC7A8Coding-0.000Candidate gene approachedHg
rs113065014NPCodingT0.227Candidate gene approachedAs
rs800590514HSP90AA1CodingT0.223Candidate gene approachedHg
rs223463614SLC39A2CodingC0.424Candidate gene approachedAs
rs1154946514HIF1ACodingT0.053Candidate gene approachedCd, Hg
rs498439015MCTP2IntronA0.318Exome chip basedHg
rs5579943815C15orf56CodingG0.047Exome chip basedCd
rs1318015IREB2CodingT0.465Candidate gene approachedCd
rs1164381516MT4CodingA0.004Candidate gene approachedHg
rs2836600316MT2AUTRG0.127Candidate gene approachedCd
rs993674116MT1MUTRC0.069Candidate gene approachedHg
rs1291971916CDH1IntronG0.164Candidate gene approachedAs
rs1107616116MT1AIntronA0.292Candidate gene approachedCd
rs414835616ABCC1CodingA0.069Candidate gene approachedPb
rs3552920916ABCC1Coding-0.000Candidate gene approachedHg
rs4139594716ABCC1Coding-0.000Candidate gene approachedHg
rs3391666116SLC7A5/CA5AIntergenicG0.119Candidate gene approachedHg
rs1107529016ABCC1IntronT0.379Candidate gene approachedHg
rs1063616MT2AUTRC0.266Candidate gene approachedCd
rs378587917LOC100130148/MAPTIntergenicA0.388Candidate gene approachedHg
rs7838844717EFCAB3ComplexG0.102Exome chip basedCd
rs24255717MAPT/LOC100130148IntergenicG0.471Exome chip basedCd
rs54293917ABHD15CodingT0.070Exome chip basedCd
rs721628417GGT6CodingA0.146Candidate gene approachedCd
rs31289317SEPT9IntronT0.163Exome chip basedCd
rs374480717PYCR1UTRT0.048Exome chip basedHg
rs266091718SOCS6/CBLN2IntergenicC0.057Candidate gene approachedCd
rs227619918PSTPIP2CodingG0.439Exome chip basedPb
rs1155589119IRGCCodingA0.132Exome chip basedHg
rs374526219RAVER1CodingC0.080Exome chip basedCd
rs1042702719PRDX2IntronC0.077Candidate gene approachedAs
rs164473119RDH8CodingA0.439Exome chip basedCd
rs445207519ZNF527CodingG0.315Exome chip basedHg
rs104367319NLRP2CodingA0.225Candidate gene approachedCd
rs376114420GSS/MYH7BIntergenicC0.463Candidate gene approachedHg
rs105672020CDC25BComplexT0.331Candidate gene approachedCd
rs276293420CYP24A1UTRA0.114Exome chip basedCd
rs492538620LAMA5IntronT0.225Exome chip basedCd
rs6220048220FERMT1CodingA0.071Exome chip basedCd
rs612655920VSTM2LIntronA0.472Exome chip basedPb
rs492003721CBSIntronA0.026Candidate gene approachedAs
rs23470921CBSIntronT0.091Candidate gene approachedAs
rs85579122TMPRSS6CodingC0.106Candidate gene approachedCd, Pb
rs98771022PRAMEL/VPREB1IntergenicG0.310Candidate gene approachedCd, Pb
rs482026822TMPRSS6CodingG0.490Candidate gene approachedCd, Pb
rs2430212XKLHL13IntronC0.299Candidate gene approachedCd, Pb

Chr.: chromosome, MAF: minor allele frequency, UTR: untranslated region.

Fig. 1

Genetic differentiation between Korean and other ethnic populations. A: Korean versus Chinese (CHB). B: Korean versus Japanese (JPT). C: Korean versus Caucasian (CEU). D: Korean versus African (YIR).

Table 3 shows that 31 SNPs had FST above 0.05 at least once in a pairwise comparison between ethnic groups. The SNP with the largest FST value between the Korean and CEU populations was rs636437, which is located in the intergenic region between replication factor C subunit 3 (RFC3) and neurobeachin (NBEA) (FST: KOR-CEU, 0.255; KOR-YIR, 0.209). The SNP with the largest FST value between the Korean and African populations was cystathionine-β-synthase (CBS) rs234709 (FST: KOR-YIR, 0.309; KOR-CEU, 0.064). The three SNPs had FST above 0.05 both in pairwise comparison between the Korean and CEU populations and between the Korean and YIR populations [vitamin D receptor (VDR) rs1544410 (FST: KOR-CEU, 0.136; KOR-YIR, 0.061), inositol polyphosphate multikinase/ZW10 interacting kinetochore protein (IPMK/ZWINT) rs4462262 (FST: KOR-CEU, 0.082; KOR-YIR, 0.207), and mitochondrial topoisomerase I (TOP1MT) rs11544484 (FST: KOR-CEU, 0.051; KOR-YIR, 0.190)].
Table 3

Allele frequencies and fixation index (FST) among different ethnics for selected 31 SNPs

SNP IDGene symbolChr.Referent/variant allele*Variant allele* frequencyKOR versus CHBKOR versus JPTKOR versus CEUKOR versus YIR





KORCHBJPTCEUYIRPFSTPFSTPFSTPFST
rs2479409BSND/PCSK91T/C0.370.320.390.650.790.1150.00080.5180.00028.1 × 10−170.02255.9 × 10−460.0620
rs10455CYBRD12G/A0.330.330.400.730.961.0000.00010.0470.00141.0 × 10−320.04674.2 × 10−1050.1343
rs1130609RRM22A/G0.340.370.350.740.980.5730.00010.8190.00011.5 × 10−190.02831.1 × 10−520.0695
rs2698530PELI1/HSPC1592T/C0.350.370.360.720.900.4670.00020.7180.00018.7 × 10−280.03888.9 ×10−790.1035
rs61197218LOC100128572/IQCA12T/G0.270.320.280.040.860.1140.00080.9310.00002.1 × 10−150.01486.8 × 10−560.0860
rs1561072SOX2OT/ATP11B3G/A0.180.190.150.100.780.5650.00030.3680.00040.0010.00331.6 × 10−970.1643
rs1830084TF/SRPRB3G/A0.470.580.500.650.913.9 × 10−40.00390.4470.00024.0 × 10−70.00809.2 × 10−530.0626
rs3817672TFRC3T/C0.180.150.190.600.140.4510.00020.6510.00013.7 × 10−420.07360.1660.0006
rs7640978CMTM63T/C0.060.050.050.100.310.7850.00030.7640.00040.0120.00265.4 × 10−360.0736
rs2725264ABCG24T/A0.220.230.190.050.920.7600.00000.3570.00023.6 × 10−110.01091.7 × 10−1320.2004
rs4073RASSF6/IL84T/C0.370.410.330.390.860.2830.00040.2970.00040.5130.00017.3 × 10−400.0546
rs2142672MYLIP/GMPR6T/C0.260.290.200.690.260.3920.00030.0330.00153.7 × 10−380.05870.8350.0001
rs2858881HLA-DQB1/HLA-DQA26T/C0.050.050.120.010.240.7670.00003.8 × 10−50.00630.0030.00194.2 × 10−260.0516
rs11544484TOP1MT8G/A0.060.080.050.300.530.1980.00090.7730.00056.4 × 10−250.05131.4 × 10−860.1900
rs10818708OR1N19T/C0.100.130.090.580.150.1410.00090.7270.00021.1 × 10−610.13000.0150.0021
rs156697GSTO210C/A0.260.270.290.390.830.7190.00010.3070.00058.9 × 10−50.00548.8 × 10−850.1262
rs4462262IPMK/ZWINT10A/G0.080.050.030.420.610.1900.00090.0020.00297.8 × 10−390.08206.4 × 10−980.2073
rs4752805PTPRJ11A/G0.210.280.190.160.980.1120.00080.7910.00000.1870.00058.5 × 10−750.1245
rs11111245NAV3/SYT112G/T0.080.090.090.000.460.4870.00000.6120.00005.5 × 10−50.00322.2 × 10−570.1166
rs1544410VDR12G/A0.050.040.110.440.270.3830.00120.0010.00465.7 × 10−560.13644.7 × 10−300.0611
rs2464196HNF1A12T/A0.450.520.380.700.900.0310.00150.0370.00146.6 × 10−130.01608.9 × 10−540.0652
rs4304840CLEC4D12A/G0.160.150.120.220.620.7300.00000.0720.00080.0320.00131.1 × 10−610.1070
rs636437RFC3/NBEA13C/T0.130.170.140.900.760.0970.00100.6080.00032.4 × 10−1330.25525.4 × 10−1130.2089
rs973968FLJ43390/KCNH514A/G0.060.040.080.170.270.3450.00000.3130.00004.2 × 10−80.01191.3 × 10−260.0508
rs55799438C15orf5615G/A0.050.060.020.410.050.2980.00080.0620.00168.6 × 10−410.10781.0000.0005
rs312893SEPT917A/G0.160.210.190.000.630.0620.00120.2260.00051.6 × 10−150.01291.8 × 10−630.1099
rs2660917SOCS6/CBLN218C/A0.060.100.050.250.300.0150.00230.7640.00036.5 × 10−190.03766.4 × 10−330.0667
rs10427027PRDX219G/A0.080.070.080.100.560.5530.00020.6990.00010.3040.00052.6 × 10−850.1802
rs234709CBS21G/A0.090.120.150.440.930.1590.00040.0120.00202.8 × 10−300.06371.3 × 10−1350.3093
rs4920037CBS21C/T0.030.010.030.230.160.3150.00040.6660.00002.5 × 10−270.06731.4 × 10−180.0379
rs2430212KLHL13XA/G0.300.360.390.240.910.2790.00050.1050.00100.1860.00075.3 × 10−720.1028

Chr.: chromosome, KOR: Koreans in this study, CHB: Han Chinese in Beijing, China, JTP: Japanese in Tokyo, Japan, CEU: Utah residents with Northern and Western European ancestry from the CEPH collection, YRI: Yoruba in Ibadan, Nigeria.

Variant allele defined as the minor allele in the Korean population.

P value calculated by Fisher’s exact test.

DISCUSSION

Our interethnic comparison study for SNPs related to the body burden of heavy metals revealed that Koreans were genetically very similar to other East Asians, including Chinese and Japanese individuals but considerably different from Caucasian and African individuals. This result was consistent with the ethnic differences in previous studies on SNPs associated with asthma (17), pharmacogenesis (18), and autoimmunity (19), although direct comparison is impossible because the studied SNPs differed. The ethnic differences in SNPs are affected by genetic drift, migration, and natural selection, and verifying these differences will help us better understand the ethnic variations in disease susceptibility and phenotypes as well as complex genetic-environment interactions (20). There are several studies reported that the body concentration of heavy metals differs across ethnicity (21,22). The U.S. National Health and Nutrition Examination Survey (NHANES) report shows that the body concentration of heavy metals in Asians was higher than in all other ethnic populations, especially for cadmium, mercury, and arsenic (23). Blood cadmium, mercury and the urinary total arsenic levels in our cohort subjects were about two, five and ten times greater than those in the U.S. population, respectively (23). Until now, it mainly focused on the ethnic differences in environmental factors including dietary habit to explain for this variation. However, our study is the first to verify the ethnic divergence in SNPs that may be related to heavy metal body burden in Koreans. In this study, CBS rs234709 showed the highest FST value compared between Korean and African individuals (FST = 0.309), and moderate genetic differentiation was observed for both CBS rs234709 and rs4920037 in the comparison between Korean and Caucasian individuals. CBS gene was-selected as a candidate gene because of the association with arsenic metabolism (24). CBS enzyme catalyzes the synthesis of cystathionine from homocysteine. A decrease in CBS activity is associated with the increases in homocysteine concentration in the body. Elevated homocysteine can deplete S-adenosylmethionine which is a methyl donor. Therefore, a modulation in CBS activity by genetic variation might affect methylation capacity in human (24–26). Recently, the evidence for this mechanism has been reported that CBS rs234709 or rs4920037 variant allele were associated with an increased in monomethylarsonous acid (a less-methylated form of arsenic metabolites), while with a decrease in dimethylarsinic acid (a more-methylated form) (25,26). That is, interethnic genetic variations in enzymes involved in arsenic metabolism can affect interethnic differences in methylation capacity, which results in ethnic differences in urine arsenic methylated metabolite compositions (26,27). In this study, there was a genetic variation between Korean and CEU populations in Transferrin receptor 1 (TFRC) rs3817672 (FST = 0.0736), which is involved in iron absorption, and VDR rs1544410 (FST = 0.1364), which is involved in calcium absorption. Because heavy metals such as cadmium and lead are not metabolized in the body, interactions with various essential minerals during absorption and excretion processes can act as an important factor that affects body burden. Deficiency of essential metals such as iron, calcium, and zinc in the body increases absorption of heavy metals such as cadmium and lead (4). Genetic factors associated with iron homeostasis were identified by several GWAS studies (28), and the association between SNPs associated with iron homeostasis and urine cadmium concentration in non-smoking women was reported (7). Comparison between Korean and CEU populations and between Korean and YIR populations revealed intergenic SNPs, including RFC3/NBEA rs636437 and IPMK/ZWINT rs4462262, with FST values that indicated moderate genetic differentiation. No studies on these two SNPs and body burden of heavy metals have been conducted to date, and the functions of these SNPs have not been identified. Only the association of IPMK/ZWINT rs4462262 with diabetes retinopathy was reported by a Taiwanese GWAS study (29). To our knowledge, this is the first report on ethnic differences in SNPs associated with the body burden of heavy metals. In this study, we presented the Koreans allele frequencies of SNPs highly associated with the body burden of heavy metals, which were selected using a candidate-gene approach and GWAS in Korean individuals, and compared the allele frequencies with those of Caucasian, African, and other ethnic Asian populations. Compared with other ethnic Asian populations such as Chinese and Japanese people, Korean individuals were not genetically different (FST < 0.05). However, compared to the Caucasian and African populations, significant differences in allele frequencies were confirmed in more than 60% of the SNPs analyzed in this study, and high genetic divergence (FST > 0.05) was observed in ten (6.1%) and 26 (16.0%) SNPs, respectively. Because there have not been many studies on the genetic effects of the body burden of heavy metals to date, ethnic differences in SNPs associated with heavy metals confirmed in this study should be considered in future studies that address ethnic differences in heavy-metal concentrations in the body and genetic susceptibility to the body burden of heavy metals.
  25 in total

1.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

2.  Gene-based single nucleotide polymorphisms and linkage disequilibrium patterns of 29 asthma candidate genes in the chromosome 5q31-33 region in Koreans.

Authors:  Ha-Jung Ryu; Ho-Youl Jung; Jung-Sun Park; Gil-Mi Ryu; Jee Yeon Heo; Jae-Jung Kim; Song-Mean Moon; Hung-Tae Kim; Jong-Young Lee; Insong Koh; Jun-Woo Kim; Jae Kyun Rho; Bok-Ghee Han; Hyungtae Kim; Choon-Sik Park; Bermseok Oh; Chan Park; Jong-Keuk Lee; Kuchan Kimm
Journal:  Int Arch Allergy Immunol       Date:  2006-01-27       Impact factor: 2.749

3.  A navigator for human genome epidemiology.

Authors:  Wei Yu; Marta Gwinn; Melinda Clyne; Ajay Yesupriya; Muin J Khoury
Journal:  Nat Genet       Date:  2008-02       Impact factor: 38.330

Review 4.  Nutrition and metal toxicity.

Authors:  R A Goyer
Journal:  Am J Clin Nutr       Date:  1995-03       Impact factor: 7.045

5.  Reference levels of blood mercury and association with metabolic syndrome in Korean adults.

Authors:  Sang-Yong Eom; Sun-Hee Choi; Su-Ju Ahn; Dong-Kyeong Kim; Dong-Won Kim; Ji-Ae Lim; Byung-Sun Choi; Hye-Jung Shin; Sin-Weon Yun; Hae-Jung Yoon; Yu-Mi Kim; Young-Seoub Hong; Yong-Woon Yun; Seok-Joon Sohn; Heon Kim; Kyung-Su Park; Hee-Soo Pyo; Ho Kim; Se-Young Oh; Jeongseon Kim; Sang-Ah Lee; Mina Ha; Ho-Jang Kwon; Jung-Duck Park
Journal:  Int Arch Occup Environ Health       Date:  2013-07-04       Impact factor: 3.015

6.  Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina.

Authors:  Craig Steinmaus; Yan Yuan; Dave Kalman; Omar A Rey; Christine F Skibola; Dave Dauphine; Anamika Basu; Kristin E Porter; Alan Hubbard; Michael N Bates; Martyn T Smith; Allan H Smith
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-17       Impact factor: 4.219

Review 7.  Heavy metal toxicity and the environment.

Authors:  Paul B Tchounwou; Clement G Yedjou; Anita K Patlolla; Dwayne J Sutton
Journal:  Exp Suppl       Date:  2012

Review 8.  A review on environmental factors regulating arsenic methylation in humans.

Authors:  Chin-Hsiao Tseng
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-30       Impact factor: 4.219

9.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.

Authors:  Danielle Welter; Jacqueline MacArthur; Joannella Morales; Tony Burdett; Peggy Hall; Heather Junkins; Alan Klemm; Paul Flicek; Teri Manolio; Lucia Hindorff; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

10.  A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults.

Authors:  Wendy McKelvey; R Charon Gwynn; Nancy Jeffery; Daniel Kass; Lorna E Thorpe; Renu K Garg; Christopher D Palmer; Patrick J Parsons
Journal:  Environ Health Perspect       Date:  2007-10       Impact factor: 9.031

View more
  3 in total

1.  Associations of TF Gene Polymorphisms with the Risk of Ischemic Stroke.

Authors:  Yi Cai; Shaofang Wu; Chaosheng Zeng; Qingjie Su; Jingxia Zhou; Pengxiang Li; Mingming Dai; Desheng Wang; Faqing Long
Journal:  J Mol Neurosci       Date:  2018-06-23       Impact factor: 3.444

2.  Exome-wide association study identifies genetic polymorphisms of C12orf51, MYL2, and ALDH2 associated with blood lead levels in the general Korean population.

Authors:  Sang-Yong Eom; Myung Sil Hwang; Ji-Ae Lim; Byung-Sun Choi; Ho-Jang Kwon; Jung-Duck Park; Yong-Dae Kim; Heon Kim
Journal:  Environ Health       Date:  2017-02-17       Impact factor: 5.984

3.  Chelation of Thallium (III) in Rats Using Combined Deferasirox and Deferiprone Therapy.

Authors:  Samie Salehi; Amir Sh Saljooghi; Somayeh Badiee; Mojtaba Mashmool Moqadam
Journal:  Toxicol Res       Date:  2015-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.